Abstract
Trophoblast implantation depends, in part, on the controlled production of plasmin from plasminogen, a process regulated by plasminogen activators and plasminogen activator inhibitors. We have determined that angiotensin II (Ang II) stimulates plasminogen activator inhibitor-1 (PAI-1) synthesis and secretion in human trophoblasts in a time- and concentration-dependent manner. Our results indicate that Ang II activates PAI-1 gene expression through the AT1 receptor and involves the calcium-dependent activation of calcineurin and the nuclear translocation of NFAT. Increased PAI-1 synthesis and secretion is associated with reduced trophoblast invasion as judged by an in vitro invasion assay. These studies are the first to link the renin-angiotensin system with the fibrinolytic system to regulate trophoblast invasion.
MeSH terms
-
Angiotensin II / pharmacology*
-
Calcineurin / physiology
-
Cell Line
-
Cyclosporine / pharmacology
-
DNA-Binding Proteins / metabolism
-
Embryo Implantation / drug effects
-
Gene Expression Regulation / drug effects
-
Humans
-
Losartan / pharmacology
-
NFATC Transcription Factors
-
Nuclear Proteins / metabolism
-
Plasminogen Activator Inhibitor 1 / biosynthesis
-
Plasminogen Activator Inhibitor 1 / genetics*
-
RNA, Messenger / drug effects
-
RNA, Messenger / genetics
-
Receptor, Angiotensin, Type 1
-
Receptors, Angiotensin / physiology*
-
Transcription Factors / metabolism
-
Transcription, Genetic / drug effects*
-
Transcriptional Activation
-
Trophoblasts / drug effects
-
Trophoblasts / physiology*
Substances
-
DNA-Binding Proteins
-
NFATC Transcription Factors
-
Nuclear Proteins
-
Plasminogen Activator Inhibitor 1
-
RNA, Messenger
-
Receptor, Angiotensin, Type 1
-
Receptors, Angiotensin
-
Transcription Factors
-
Angiotensin II
-
Cyclosporine
-
Calcineurin
-
Losartan